Point72 Asset Management
FULC icon

Point72 Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Point72 Asset Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.9M Sell
2,074,855
-323,377
-13% -$3M 0.02% 938
2025
Q4 		$27.1M Buy
+2,398,232
New +$24.4M 0.03% 710
2025
Q3 		– Sell
-498,219
Closed -$3.43M – 2444
2025
Q2 		$3.43M Buy
+498,219
New +$2.66M 0.01% 1105
2024
Q2 		– Sell
-223,400
Closed -$2.11M – 2058
2024
Q1 		$2.11M Buy
+223,400
New +$1.99M 0.01% 1251
2023
Q3 		– Sell
-1,899,968
Closed -$6.27M – 2603
2023
Q2 		$6.27M Sell
1,899,968
-743,704
-28% -$2.19M 0.02% 743
2023
Q1 		$7.53M Buy
+2,643,672
New +$23.7M 0.02% 636
2022
Q4 		– Sell
-1,494,003
Closed -$12.1M – 1610
2022
Q3 		$12.1M Sell
1,494,003
-494,797
-25% -$3.54M 0.05% 454
2022
Q2 		$9.74M Buy
1,988,800
+1,663,800
+512% +$16.3M 0.04% 512
2022
Q1 		$7.69M Sell
325,000
-180,655
-36% -$2.56M 0.03% 582
2021
Q4 		$8.95M Buy
505,655
+365,655
+261% +$7.24M 0.04% 540
2021
Q3 		$3.95M Sell
140,000
-412,885
-75% -$7.82M 0.02% 703
2021
Q2 		$5.79M Sell
552,885
-22,361
-4% -$226K 0.03% 583
2021
Q1 		$6.78M Sell
575,246
-762,877
-57% -$9.43M 0.03% 518
2020
Q4 		$15.7M Sell
1,338,123
-171,877
-11% -$1.94M 0.08% 337
2020
Q3 		$12M Buy
1,510,000
+1,249,303
+479% +$15M 0.06% 375
2020
Q2 		$4.77M Buy
+260,697
New +$4.1M 0.03% 490

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Point72 Asset Management's FULC Position: Q1 2026 in Review

Point72 Asset Management reduced its Fulcrum Therapeutics (FULC) stake by 13% in Q1 2026, selling an estimated $3M and leaving 2,074,855 shares worth $15.9M. The position accounts for 0.02% of the portfolio, ranked #938.

Point72 Asset Management first reported a position in FULC in Q2 2020 and has held it in 16 quarters since. The position peaked at $27.1M in Q4 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Point72 Asset Management held 2,074,855 shares of Fulcrum Therapeutics worth $15.9M as of Q1 2026.
  • Point72 Asset Management sold 323,377 Fulcrum Therapeutics shares in Q1 2026, an estimated $3M.
  • Fulcrum Therapeutics made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #938 holding.
  • Point72 Asset Management first reported a position in Fulcrum Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • Point72 Asset Management's Fulcrum Therapeutics position peaked at $27.1M in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.